Hebei Medical University Fourth Hospital
2 clinical trials · 2 recruiting · OTHER
Trials by Hebei Medical University Fourth Hospital
RECRUITINGPhase 2NCT04138719
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
This is a multicenter, open, randomized, comparison study. Triple-negative breast cancer (TNBC) is a term applied to breast cancer cases that have \<1% expression of the estrogen...
Sponsor: Hebei Medical University Fourth HospitalEnrolling: 5201 location
Breast CancerTriple-negative Breast CancerNab-paclitaxel
RECRUITINGPhase 2NCT07290010
The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line...
This study is a single-arm clinical trial to evaluate the efficacy and safety of Iparomlimab and Tuvonralimab combined with chemotherapy in the first-line treatment of patients...
Sponsor: Hebei Medical University Fourth HospitalEnrolling: 251 location
Esophageal Squamous Cell Carcinoma (ESCC)